How to Read an NMN Supplement Label in Australia: The TGA Guide

Consumer Education Guide · Updated June 2026

Since the TGA's December 2025 approval of NMN as a therapeutic ingredient, Australian NMN supplement labels have become more informative — and more confusing. AUST L numbers, GMP certifications, purity percentages, and isomer specifications are appearing on labels that previously just said "NMN 500mg."

For buyers, this creates opportunity: more information to evaluate quality. And risk: more marketing language that sounds meaningful but may not be. This guide decodes every element of an Australian NMN label systematically — what each claim means, what it does not mean, and what should be on a label that is not there.

AUST L and AUST R Numbers: What They Mean

AUST L (Listed medicines): The product has been registered on the Australian Register of Therapeutic Goods (ARTG). For listed medicines, manufacturers self-certify compliance with TGA standards — the TGA does not independently verify every ingredient claim before listing. However, the TGA can and does audit listed products and has powers to remove them if claims are found to be false.

AUST R (Registered medicines): Higher-risk products individually evaluated by the TGA for safety, quality, and efficacy before approval. Stronger regulatory scrutiny than Listed medicines.

What AUST L means in practice: The brand has committed to TGA compliance standards and is subject to audit. It is a meaningful accountability signal — brands will not risk ARTG listing for a product that would obviously fail testing. It does not guarantee every label claim is independently verified by a government body.

Products without an AUST number: Can still be legally sold as general health products (not making therapeutic claims), but are not subject to TGA therapeutic standards. Most imported supplements fall into this category.

Dose Claims: What to Accept and What to Question

Beta-NMN vs Just NMN: The Isomer Question

NMN exists in two molecular orientations: the beta-isomer (bioactive, used in all human clinical trials) and the alpha-isomer (less bioactive). Most commercially produced NMN is predominantly the beta-isomer — but some lower-grade products may be racemic (a mixture) without disclosing this.

Quality labels will specify beta-NMN or >99% beta-isomer. Labels that simply say "NMN" without isomer specification are not necessarily inferior — but they are less transparent. The Certificate of Analysis should confirm beta-isomer purity regardless of what the label states.

Purity Claims: Pharmaceutical-Grade and What It Means

"Pharmaceutical-grade NMN": Meaningful when backed by a Certificate of Analysis confirming >98–99% purity via HPLC. Marketing language when used without a CoA. This phrase has no regulatory definition — any brand can use it.

"GMP certified": Meaningful as a manufacturing standard indicator. GMP (Good Manufacturing Practice) requires documented quality control, cleanliness standards, and process validation. Worth verifying — the brand should be able to name the certified facility and its GMP certification body.

"Third-party tested": Meaningful when the Certificate of Analysis is published and accessible. Marketing language when the CoA is not publicly available — you cannot verify claims without the document.

Certificate of Analysis: What It Should Contain

A genuine, useful Certificate of Analysis for NMN should include:

1. NMN identity confirmation — HPLC method confirming the molecule is actually NMN (not nicotinamide or another compound)
2. NMN potency — actual milligrams verified per serving, compared to label claim
3. Beta-isomer purity percentage — >98% is the quality standard for pharmaceutical-grade
4. Heavy metals panel — lead, arsenic, cadmium, mercury — with specific numerical results against safe limits
5. Microbial contamination — total plate count, E.coli, Salmonella, Staphylococcus
6. Batch number — matching the product you purchased or can purchase
7. Testing laboratory identity — an accredited independent lab, not affiliated with the manufacturer

Nadovia publishes this complete CoA for every batch — downloadable from our website before you buy.

Red Flags on NMN Labels

• Proprietary blend hiding NMN dose — no legitimate reason to hide the NMN dose in a proprietary blend
• "Pharmaceutical-grade" without a published CoA — an unverifiable claim
• Third-party tested with no accessible CoA — meaningless without the document
• No batch number on the product — you cannot match a CoA to an unbatched product
• Clinical dose claims at 125mg or 250mg without noting the evidence base — misleading dose framing
• Gelatin capsules for a "vegan" claim — check the capsule material explicitly

FAQ

References: tga.gov.au — ARTG and listed medicines guidance; TGA NMN approval December 2025; ConsumerLab NMN testing (2024). Not regulatory advice.